← Evidence map

ArticleCritical care (London, England)2020

Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19.

Melvin Khee Shing LeowPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32631373